TRC Global Rankings
Menu
TRC Global Rankings
Racing
Breeding and Sales
What They’re Thinking
View From The Rail
Commentary
Lasix
|<
<
1
2
3
>
>|
Commentary
How phasing out U.S. race-day medication may affect the European sales market
Geir Stabell
|
Oct 16, 2019
|
What They’re Thinking
What Jonathan Sheppard loves about racing - and what he wishes had never been invented
Bob Ehalt
|
Aug 7, 2018
|
View From The Rail
View from the Rail: forget Lasix for now - let’s solve the fundamental issue first
Charles Hayward
|
Apr 24, 2018
|
Racing
How would U.S. racing work in a brave new drug-restricted world?
Daniel Ross
|
Apr 17, 2017
|
Racing
A champion of reform, but the NTRA ‘must remain neutral on Barr-Tonko’
Amanda Duckworth
|
Aug 18, 2016
|
Breeding and Sales
Drugs and medication in racing: ‘it’s like the Mad Hatter’s tea party’
John Gilmore
|
Mar 18, 2016
|
Breeding and Sales
International turf superstar Flintshire to be trained in the U.S.
John Gilmore
|
Mar 2, 2016
|
Racing
Kiaran McLaughlin: the day I realized horses don't need to run on medication
Karen M Johnson
|
Jan 29, 2016
|
Racing
How Jimmy Jerkens uncovered the key to Effinex
Karen M Johnson
|
Dec 11, 2015
|
Racing
Mark Casse: the reasons race-day Lasix is essential in America
Karen M Johnson
|
Nov 24, 2015
|
|<
<
1
2
3
>
>|
Keep up-to-date with all the latest news and views
Join the TRC Mailing List
Areas of Interest
All
Racing
Breeding
Wagering
Owners / Trainers / Jockeys
Equine Welfare
* Required field
Privacy Policy
Sign Up
I would like to receive news and special offers from carefully selected partners of Thoroughbred Racing Commentary